a magnifying glass

adobe pdf icon Analogic Corporation Elects Fred B. Parks to Its Board of Directors

Analogic Corporation Elects Fred B. Parks to Its Board of Directors

Analogic Corporation Elects Fred B. Parks to Its Board of Directors

PEABODY, Mass.–(BUSINESS WIRE)–Aug. 29, 2007–Bernard M. Gordon,
Chairman of the Board of Analogic Corporation (NASDAQ: ALOG),
announced today that Fred B. Parks, Ph.D., Chairman of the Board and
Chief Executive Officer of Urologix, Inc. (NASDAQ: ULGX), of
Minneapolis, Minnesota, has been elected to the Company’s Board of
Directors as a Class III Director, whose term will expire in 2010.

Prior to 2003, Dr. Parks was Chief Executive Officer of Philips
Medical Systems – Cleveland, formerly Marconi Medical Systems. Dr.
Parks holds three degrees in Mechanical Engineering, a B.S. from the
University of Missouri-Rolla, an M.S. from the University of Arizona,
and a Ph.D. from the University of Missouri-Columbia. He has been
appointed to the Nominating and Corporate Governance and the
Compensation Committees.

Mr. Gordon commented, “Clearly, Fred has a wealth of experience in
high-technology enterprises. We welcome Fred to Analogic’s Board of
Directors and look forward to working with him to further strengthen
the Company.”

Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems. The Company is
recognized worldwide for advancing the state of the art in Automated
Explosives Detection, Computed Tomography (CT), Digital Radiography
(DR), Ultrasound, Magnetic Resonance Imaging (MRI), Patient
Monitoring, and Advanced Signal Processing. For more information,
please visit www.analogic.com.

CONTACT:
Analogic Corporation
Bernard M. Gordon
978-326-4000
Chairman of the Board
or
Paul M. Roberts
978-326-4213
Director of Communications
proberts@analogic.com

SOURCE:
Analogic Corporation